Hongtao Tie

The First Affiliated Hospital of Chongqing Medical University

Dr. Hongtao Tie is currently a thoracic surgeon at the First Affiliated Hospital of Chongqing Medical University. He completed his Doctor of Medicine at Universitätsklinikum Münster, University of Münster. Dr. Tie received the 2021 China Outstanding Self-funded International Student Award and the 2024 Oriental Rising Star Award from the Asian Society of Thoracic and Cardiovascular Surgery.In recent years, his research has focused on the molecular mechanisms of organ ischemia/reperfusion injury and the clinical aspects of thoracic diseases. As the first or corresponding author, he has published over 30 papers in prominent journals, including the Journal of Heart and Lung Transplantation, Circulation: Heart Failure, Critical Care, and the European Journal of Cardio-Thoracic Surgery.Additionally, Dr. Tie is a young editorial board member of the Chinese Clinical Journal of Thoracic and Cardiovascular Surgery, an editorial board member of BMC Cardiovascular Disorders, and a young editorial board member of Cardiovascular Innovations and Applications.

Ming Li

Zhongshan Hospital, Fudan University

Dr. Ming Li, MD, is a thoracic surgeon and assistant researcher in the Department of Thoracic Surgery at Zhongshan Hospital, Fudan University in Shanghai, China. He earned his medical degree from Fudan University and completed residency training in surgery (2022–2024), followed by fellowship training in thoracic surgery. His clinical and research focus lies in minimally invasive thoracic surgery and translational cancer research, particularly in applying optical technologies and artificial intelligence to thoracic procedures.Dr. Li has served in several editorial roles, including associate editor for BMC Cancer, BMC Pulmonary Medicine, and the European Journal of Medical Research, as well as section editor for the Annals of Translational Medicine. He has also been a guest editor for Frontiers in Oncology.An active member of organizations such as CSCO, CACA, ESMO, and IASLC, Dr. Li has presented at major conferences including AATS, ESTS, JATS, and WCLC. He is a recipient of the IASLC International Mentorship Award (WCLC 2024) and holds multiple national research grants, including support from NSFC and China’s National Postdoctoral Innovation Talents Program.

Zerui Zhao

Department of Thoracic Surgery, Sun Yat-Sen University Cancer Center

Dr. Zerui Zhao completed his surgical training at Sun Yat-Sen University and earned his PhD from the Chinese University of Hong Kong in 2018. He is currently an associate professor in the Department of Thoracic Surgery at Sun Yat-Sen University Cancer Center. His academic and clinical interests focus on extended resection for locally advanced non-small cell lung cancer following neoadjuvant treatment. He is also passionate about exploring novel induction modalities, such as stereotactic body radiation therapy (SBRT) combined with sequential immunochemotherapy and targeted therapy for lung cancer.Dr. Zhao has published over 20 peer-reviewed articles in the fields of general thoracic surgery and lung cancer, appearing in prestigious journals such as Lancet Respiratory Medicine, Journal of Thoracic and Cardiovascular Surgery, Journal of Thoracic Oncology, and Annals of Thoracic Surgery. Additionally, he has contributed book chapters to notable texts, including the 8th Edition of Shield’s General Thoracic Surgery and the 4th Edition of Thoracic & Esophageal Surgery.

Jianfei Shen

Zhejiang Taizhou Hospital

Dr. Jianfei Shen has been employed at Taizhou Enze Medical Center (Group) since August 2016 and has served as the Deputy Chief Physician of Cardiothoracic Surgery since 2020. His primary focus is on clinical and scientific research related to lung cancer, esophageal cancer, and heart disease. Dr. Shen has extensive experience in researching lung and esophageal tumors and has published over 50 SCI papers as the first, co-first, or corresponding author. His work has appeared in prestigious journals such as JCO, JTCVS, JSO, and Cell Oncol, with a cumulative impact factor exceeding 200 and a total citation count of over 360. He has also contributed to the development of perioperative rapid recovery protocols and clinical biopsy guidelines for lung cancer, with publications in J Thorac Dis (2018) and Transl Lung Cancer Res (2019). Additionally, Dr. Shen has held various editorial roles, serving as editor, deputy chief translator, or co-editor for five books.